[Screening of high-risk group with colorectal cancer].
OBJECTIVE
To measure the rate of high-risk group and the detection rate of colorectal cancer (CRC) in communities in Guangdong province and to provide scientific rationales for formulating mass screening plans in high-risk group.


METHODS
Mass survey was conducted by questionnaire combined fecal occult blood test (FOBT) in Huizhou region, Guangdong Province, to sort out the high-risk population of CRC. Then the high-risk population was screened by colonoscopy and pathology to identify CRC. The differences were compared by direct expenditure which was used to calculate screening cost.


RESULTS
A total of 68,953 people were surveyed. There were 940 people in high-risk group (detection rate: 1.36%), 3118 in immunity FOBT positive group (detection rate: 4.52%), Merging aforementioned two groups, there were 3870 in population at risk (detection rate: 5.61%). The CRC detection rate in high-risk group, immunity FOBT positive group, population at risk and average-risk group was 506.3/10(5), 314.3/10(5), 315.9/10(5) and 17.7/10(5) respectively. The positive predictive value of CRC screening scheme by high-risk group questionnaire-colonoscopy was 0.43% while CRC screening scheme by FOBT-colonoscopy 0.22%. In terms of direct expenditure of CRC per case in high-risk group and immunity FOBT positive group was 47,834.5 yuan and 82,303.6 yuan. The latter was 1.7 times than that of the former.


CONCLUSIONS
The scheme of questionnaire combined FOBT for CRC is an effective way in mass survey. The scheme by high-risk group questionnaire-colonoscopy has a much better cost-effectiveness than that of the scheme by FOBT-colonoscopy so that it should be one of the preferred methods for individual screening in high-risk group.
Xu
An-gao
AG
Department of Gastroenterology, Huizhou Municipal Central Hospital, Huizhou Institute of Medicine, Guangdong Province, Huizhou 516001, China. angao62@21cn.com
Yu
Zhi-jin
ZJ
Zhong
Xu-hui
XH
Gan
Ai-hua
AH
Liu
Ji-hong
JH
Luo
Qiu-yun
QY
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000517:prevention & control*; D003362:Cost-Benefit Analysis; D006801:Humans; D007223:Infant; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D008875:Middle Aged; D011795:Surveys and Questionnaires; D055815:Young Adult